15 May 2021 in Problems of Virology
Introduction. The pandemic spread of a new coronavirus infection, COVID-19, has caused a global emergency and attracted the attention of public health professionals and the population of all countries. A significant increase in the number of new cases of SARS-CoV-2 infection demonstrates the urgency of finding drugs effective against this pathogen.The aim of this work was to evaluate the in vitro antiviral efficacy of human recombinant alpha-2b interferon (IFN-α2b) against SARS-CoV-2 virus.Material and methods. The experiments had been carried out on Vero Cl008, the continuous line of African green monkey (Chlorocebus sabaeus) kidney cells. The effectiveness of the drugs was assessed by the suppression of viral reproduction in vitro. The biological activity was determined using titration of a virus-containing suspension in a Vero Cl008 cell culture by the formation of negative colonies.Results. The antiviral efficacy of the IFN-α2b-based medications, which have a high safety profile and proven efficacy in the prevention and treatment of influenza and acute respiratory viral infections (ARVI), has been studied against the new pandemic SARS-CoV-2 virus in vitro experiments in Vero C1008 cell culture. IFN-α2b effectively inhibits the reproduction of the virus when applied both 24 hrs before and 2 hrs after infection. In the IFN-α2b concentration range 102–106 IU/ml a complete suppression of the reproduction of the SARS-CoV-2 virus had been demonstrated.Discussion. IFN-α2b demonstrated in vitro high antiviral activity against SARS-CoV-2. In addition, the substance has a high chemotherapeutic index (1000).Conclusion. Medications for intranasal use based on IFN-α2b have high antiviral activity and are promising drugs for in vivo study in terms of prevention and treatment of COVID-19.
29 April 2023 in Antibiot Khimioter = Antibiotics and Chemotherapy
The Сhikungunya virus (CHIKV) is a member of the Flavivirus genus, the Flaviviridae family, and is a zoonotic arbovirus infection transmitted by Aedes mosquitoes. Chikungunya fever causes explosive epidemics involving millions of cases. There is an urgent need to develop broad-spectrum antivirals. Actual is the development of a model of screening in vitro effective drugs. To select the optimal screening conditions, a comparative analysis of cell cultures sensitivity to Сhikungunya virus, strain FN198/66 was carried out. The dynamics and level of virus accumulation at different infectious doses were estimated. It is shown that the Сhikungunya virus, strain FN198/66, well propagated in transplantable cell cultures Vero V, Сl008 Vero, BHK-21/13 and TC-17. All studied cell lines can be used to screen for effective non-specific medical defenses against Сhikungunya virus.
28 December 2022 in Antibiot Khimioter = Antibiotics and Chemotherapy
The COVID-19 virus has caused a global emergency and has attracted the attention of healthcare professionals and the public around the world. The significant increase in the number of new cases of infection with this virus demonstrates the relevance of the search for drugs that are effective against this pathogen. The aim of this work was to evaluate the antiviral efficacy of Mefloquin® against COVID-19. The antiviral efficacy of Mefloquin® against the new pandemic virus SARS-CoV-2 was studied in in vitro experiments in Vero C1008 cell culture and in vivo on Syrian golden hamsters. The results of the study revealed that the drug Mefloquine® at a concentration of 2.0 µg ml-1, when applied after infection of cells, suppresses the reproduction of the SARS-CoV-2 virus by 1.7–1.9 lg, the inhibition rate is about 99%. When using Mefloquine, pathological changes in the lung tissue were less pronounced than in the control group. 6 days after infection, it was shown that when using Mefloquine, there was a statistically significant decrease in viral load in the lungs of infected Syrian golden hamsters, with an inhibition rate of 95.5%.
11 February 2023 in Antibiot Khimioter = Antibiotics and Chemotherapy
Сhikungunya virus (CHIKV) is a member of the Flavivirus genus, Flaviviridae family. It belongs to the zoonotic arbovirus infections transmitted by mosquitoes of the genus Aedes. In humans, this flavivirus causes a disease known as Сhikungunya fever, etymologically related to yellow fever, dengue, West Nile, and Zika. There is no specific treatment for Сhikungunya fever, as there is no vaccine or preventive measures to date. A comparative analysis of the effectiveness of chemotherapy drugs, interferon inducers and two classes of interferon α-, β-, and γ-showed that interferon drugs effectively inhibit the reproduction of CHIKV in the Vero cell culture in a wide range of concentrations. Chemotherapy drugs Triazavirin® and Ingavirin® did not affect the reproduction of CHIKV strain FN198/66 in Vero cell culture. Ribavirin® at a concentration of 100 µg/ml almost completely suppressed the reproduction of the CHIKV virus when the drug was introduced into the culture medium both before and after infection.
19 April 2025 in Antibiot Khimioter = Antibiotics and Chemotherapy
Introduction. The viral disease COVID-19 has caused a global emergency. The rapid and widespread spread of COVID-19 and the urgent need for etiotropic drugs have sparked interest in repositioning existing drugs. SARS-CoV proteases (Mpro) and papain protease (PLpro) have been identified as attractive targets for the development of antiviral agents.The aim of this work was to evaluate the antiviral efficacy of indole chloropyridinyl ethers against the SARS-CoV-2 virus in vitro, as well as against the experimental form of COVID-19 in Syrian golden hamsters.Material and methods. The experiments were carried out on a permanent culture of African green monkey kidney cells — Vero Cl008. The effectiveness of the drugs was assessed by suppressing the reproduction of the virus in vitro. Biological activity was assessed by titration of the viruscontaining suspension in Vero Cl008 cell culture by the formation of negative colonies. Syrian golden hamsters orally infected with the SARS-CoV-2 virus, variant B, were used. The effectiveness of the drug was assessed by the coefficient of therapeutic action.Results. The antiviral efficacy of indole chloropyridinyl ethers against the new pandemic virus SARSCoV-2 was studied in vitro during experiments in Vero C1008 cell culture. The results of the study revealed that the drugs effectively suppress the reproduction of the virus when applied after infection. In the concentration range of 12.5–50.0 µg/ml, the drugs almost completely suppress the reproduction of the SARS-CoV-2 virus. According to the complex of clinical, virological, biochemical, and hematological indicators, the disease severity indех (DSI) and the therapeutic action coefficient (TAC) were calculated. For AMND-1X — the DSI was 0.635; the TAC was 36.5%; for AMND-1OL-3 — the DSI was 0.115; the TAC was 88.5%. Conclusion. Of the studied compounds, the drug AMND-1OL-3 showed the highest antiviral activity.
6 August 2025 in Antibiot Khimioter = Antibiotics and Chemotherapy
Viral infections occupy a leading place in various human pathologies and are one of the main causes of death among people, both in developed and developing countries with a weak health care system. The huge diversity of viruses and their unique variability pose a serious challenge to the developers of antiviral agents. The purpose of this review is to analyze the current state of development of emergency prevention and treatment agents, as well as promising areas for the development of chemotherapy for viral infections. The main direction in the development of effective means for the treatment of viral infections is the creation of medications based on abnormal nucleosides and their precursors, small interfering RNA, releaseactive compounds, and the search for targets among viral proteins. The review considers the most significant results in the field of creating agents for the treatment of viral infections.